Peter B. McClung - 11 Aug 2025 Form 4 Insider Report for AIR T INC (AIRT)

Reporting relationship: Director
Issuer ticker: AIRT
Reported as of: 11 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Aug 2025, 15:46:49 UTC
Prior SEC filing: 20 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Peter B. McClung

Key filing fact

Peter B. McClung filed Form 4 for AIR T INC (AIRT) on 14 Aug 2025.

Key facts

This page summarizes Peter B. McClung's Form 4 filing for AIR T INC (AIRT).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 14 Aug 2025, 15:46.

Change

Previous filing in this sequence was filed on 20 Sep 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001741746 Primary reporting owner

McClung Peter B.

Relationship: Director
Address: 14101 SOUTHERN ROAD, GRANDVIEW
Signature: /s/ Peter B. McClung
Signature date: 14 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AIRT transaction Derivative

Stock options

Award

Transaction value: $0
Shares: +500
Change %
Price: $0.000000
Shares after: 500
Date: 11 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500
Exercise price: $30.00
Footnotes: F1

AIRT transaction Derivative

Stock options

Award

Transaction value: $0
Shares: +500
Change %
Price: $0.000000
Shares after: 500
Date: 11 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500
Exercise price: $50.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Cumulative amount does not include presently unexerciseable options granted in December 2020. Whether any of the unexerciseable options vest, and the amount that does vest, is tied to various price tranches (six per year) corresponding to future testing dates (June 30 of each year) and the achievement of our Common Stock trading at or above the exercise price for each applicable price tranche. In the event that the market price of our common stock does not reach or exceed the exercise price during the 60 days immediately preceding the applicable price tranche, 100% of the applicable options associated with that price tranche expire immediately. After expirations due to failures to reach the prior stated exercise prices, total amount currently outstanding is 1,500. For further details, see the Company's proxy statement filed July 3, 2025.